Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Bossi A, Foulon S, Maldonado X, Sargos P, MacDermott R, Kelly P, Fléchon A, Tombal B, Supiot S, Berthold D, Ronchin P, Kacso G, Salem N, Calabro F, Berdah JF, Hasbini A, Silva M, Boustani J, Ribault H, Fizazi K; PEACE-1 investigators. Bossi A, et al. Among authors: boustani j. Lancet. 2024 Nov 23;404(10467):2065-2076. doi: 10.1016/S0140-6736(24)01865-8. Lancet. 2024. PMID: 39580202 Clinical Trial.
Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma.
Baude J, Guigou C, Thibouw D, Vulquin N, Folia M, Constantin G, Boustani J, Duvillard C, Ladoire S, Truc G, Bertaut A, Chevalier C. Baude J, et al. Among authors: boustani j. PLoS One. 2024 Jul 25;19(7):e0307658. doi: 10.1371/journal.pone.0307658. eCollection 2024. PLoS One. 2024. PMID: 39052674 Free PMC article.
Targeting two radiation-induced immunosuppressive pathways to improve the efficacy of normofractionated radiation therapy in a preclinical colorectal cancer model.
Boustani J, Lecoester B, Baude J, Latour C, Limagne E, Ladjohoulou R, Morgand V, Froidurot L, Ghiringhelli F, Truc G, Adotévi O, Mirjolet C. Boustani J, et al. Int J Radiat Biol. 2024;100(6):912-921. doi: 10.1080/09553002.2024.2331115. Epub 2024 Mar 20. Int J Radiat Biol. 2024. PMID: 38506658
Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU).
Ah-Thiane L, Sargos P, Chapet O, Jolicoeur M, Terlizzi M, Salembier C, Boustani J, Prevost C, Gaudioz S, Derashodian T, Palumbo S, De Hertogh O, Créhange G, Zilli T, Supiot S. Ah-Thiane L, et al. Among authors: boustani j. Cancer Treat Rev. 2023 Nov;120:102626. doi: 10.1016/j.ctrv.2023.102626. Epub 2023 Sep 16. Cancer Treat Rev. 2023. PMID: 37734178 Review.
Chemotherapy to potentiate the radiation-induced immune response.
Lecoester B, Wespiser M, Marguier A, Mirjolet C, Boustani J, Adotévi O. Lecoester B, et al. Among authors: boustani j. Int Rev Cell Mol Biol. 2023;376:143-173. doi: 10.1016/bs.ircmb.2023.01.004. Epub 2023 Feb 11. Int Rev Cell Mol Biol. 2023. PMID: 36997268 Review.
31 results